CASP1 and plasma cell myeloma: GSK591, an inhibitor of protein arginine methyltransferase 5 (PRMT5), lowers H4R3me2s levels at the caspase-1 promoter, thereby elevating caspase-1 expression and inducing pyroptosis in multiple myeloma cells56.